We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





HORIBA Medical Launches HELO and Yumizen G Range

By LabMedica International staff writers
Posted on 05 Feb 2018
HORIBA Medical (Montpellier, France) showcased and launched the HELO island configuration solution and the new Yumizen G Range of coagulation analyzers at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference.
 
HORIBA Medical is one of the five segments of the Japanese HORIBA Group and one of the global leaders in the hematology market. More...
At the MEDLAB Middle East 2018 held from February 5-8, 2018 in Dubai, UAE, the company showcased HELO (HORIBA Evolutive Laboratory Organization), an innovative design solution covering all the needs of high throughput automated hematology platforms. The HELO solution is based on four fundamentals pillars: using reference methods to count cells, simplifying the user interface with its solution, consider tube workflow management differently from the competition and purpose a scalable solution to fit laboratory needs. With features such as high throughput of 120 samples per hour, automatic slide maker/stainer, comprehensive automated slide digitalization, automated conveyor with multi possible configurations, hematology middleware and expert validation station, HELO provides the optimum answer to the constant evolution of the laboratory.
 
HORIBA Medical also showcased the new Yumizen G Range of coagulation analyzers, which includes the Yumizen G1550, Yumizen G800, Yumizen G400, Yumizen G200 and Yumizen G100. The Yumizen G100 is the smallest analyzer for point of care laboratories to monitor oral anticoagulant, whereas the Yumizen G1550 is a fully automated, high-capacity coagulation analyzer to manage the diagnostic and monitoring requirements of clinical laboratories with mid to high workload. 
 

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.